IMiDs downregulate the expression of HLA class I molecules on AML cells, increase their disruption by NK cells and raise the expression of crucial ligands (particularly ligands of DNAM-1 and NKG2D) involved in blasts recognition [12,15]. Here, KLRK1 is linked to acute myeloid leukemia.